Dr Reddys Laboratories (RDY) Invested Capital (2009 - 2026)

Dr Reddys Laboratories (RDY) has reported Invested Capital for 18 consecutive years, with $630.0 million the latest figure, recorded in Q1 2026.

• Quarterly Invested Capital rose 41.57% year-over-year to $630.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 43.32% YoY) and the FY2026 annual result came in at $630.0 million, up 41.57% from the prior year.
• Invested Capital improved to $630.0 million in Q1 2026 per RDY's latest filing, from $445.0 million in the prior quarter.
• Over the last five years, Invested Capital for RDY reached as high as $630.0 million in Q1 2026 and fell as low as $13.0 million in Q1 2022.
• A 5-year average of $258.9 million and a median of $254.0 million in 2023 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2024 — Invested Capital tumbled 93.7% — and 2025, when it soared 2681.25%.
• Year by year, Invested Capital stood at $301.0 million in 2022, then tumbled by 49.17% to $153.0 million in 2023, then sank by 89.54% to $16.0 million in 2024, then surged by 2681.25% to $445.0 million in 2025, then soared by 41.57% to $630.0 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $630.0 million, $445.0 million, and $16.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.